Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06430736

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-07-08

100

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Despite the consequent use of Tocilizumab together with conventional antipyretics at early/first signs of emerging CRS, CRS (and eventually the subsequent development of ICANS) remain a major concern for patients. This study aims to identify safety and efficacy of prophylactic Tocilizumab treatment. In particular, to explore whether prophylactic Tocilizumab treatment can decrease the incidence and severity of CRS (and subsequent eventual neurotoxicity) following CAR-T-treatment.

CONDITIONS

Official Title

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients planned to receive commercial CAR-T treatment for lymphoma, leukemia, or myeloma at Bern Inselspital
  • Provided written informed consent
  • Considered clinically fit for CAR-T treatment by the investigator
  • Aged 18 years or older
Not Eligible

You will not qualify if you...

  • Previous Tocilizumab treatment within 3 months prior to CAR-T infusion
  • Treatment with an investigational drug within 8 weeks before CAR-T infusion
  • Women who are pregnant, breastfeeding, or planning pregnancy during the study without safe contraception
  • Inability to follow study procedures due to language, psychological, or cognitive issues
  • Previous participation in this study
  • Investigator or family members or employees involved in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Insel Gruppe AG

Bern, Canton of Bern, Switzerland, 3010

Actively Recruiting

Loading map...

Research Team

T

Thomas Pabst, Prof.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here